Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

× No keyword cloud information.

20 in total

1. A placebo controlled trial of viloxazine with and without tranquillizers in depressive illness.

Authors: R V Magnus
Journal: J Int Med Res Date: 1975 Impact factor: 1.671

2. A double-blind controlled study of viloxazine and imipramine in depression.

Authors: I K Tsegos; M Y Ekdawi
Journal: Curr Med Res Opin Date: 1974 Impact factor: 2.580

3. Gas-liquid chromatographic estimation in blood of ICI 58 834.

Authors: D E Case
Journal: J Pharm Pharmacol Date: 1973-10 Impact factor: 3.765

4. The clinical pharmacology of viloxazine hydrochloride-a new anti-depressant of novel chemical structure.

Authors: P F Bayliss; S M Duncan
Journal: Br J Clin Pharmacol Date: 1974-10 Impact factor: 4.335

5. The disposition and metabolism of I.C.I. 58,834 (viloxazine) in humans.

Authors: D E Case; P R Reeves
Journal: Xenobiotica Date: 1975-02 Impact factor: 1.908

6. Cases of overdosage with viloxazine hydrochloride (Vivalan).

Authors: R D Brosnan; A M Busby; R P Holland
Journal: J Int Med Res Date: 1976 Impact factor: 1.671

7. Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.

Authors: W Lippman; T A Pugsley
Journal: Can J Physiol Pharmacol Date: 1976-08 Impact factor: 2.273

8. The disposition and metabolism of I.C.I. 58,834 (viloxazine) in animals.

Authors: D E Case; H Illston; P R Reeves; B Shuker; P Simons
Journal: Xenobiotica Date: 1975-02 Impact factor: 1.908

9. [Doubleblind study with the novel antidepressant viloxazine versus imipramine in 50 in-patients (author's transl)].

Authors: L Floru; G Czarny; J Tegeler
Journal: Arzneimittelforschung Date: 1976

10. [Studies on a novel antidepressant (viloxazin) by means of time-series analysis of TV data].

Authors: E Renfordt; H Busch; E Fähndrich; B Müller-Oerlinghausen
Journal: Arzneimittelforschung Date: 1976

23 in total

1. Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction.

Authors: F Pisani; A Fazio; C Artesi; M Russo; R Trio; G Oteri; E Perucca; R Di Perri
Journal: J Neurol Neurosurg Psychiatry Date: 1992-02 Impact factor: 10.154

2. Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment.

Authors: F Pisani; A Fazio; E Spina; C Artesi; B Pisani; M Russo; R Trio; E Perucca
Journal: Psychopharmacology (Berl) Date: 1986 Impact factor: 4.530

10. The effect of some antidepressants on prejunctional muscarinic receptors on the sympathetic nerves of the isolated rabbit ear artery.

Authors: Y H Kwok; F Mitchelson
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1982-07 Impact factor: 3.000

Viloxazine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

1. A placebo controlled trial of viloxazine with and without tranquillizers in depressive illness.

2. A double-blind controlled study of viloxazine and imipramine in depression.

3. Gas-liquid chromatographic estimation in blood of ICI 58 834.

4. The clinical pharmacology of viloxazine hydrochloride-a new anti-depressant of novel chemical structure.

5. The disposition and metabolism of I.C.I. 58,834 (viloxazine) in humans.

6. Cases of overdosage with viloxazine hydrochloride (Vivalan).

7. Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities.

8. The disposition and metabolism of I.C.I. 58,834 (viloxazine) in animals.

9. [Doubleblind study with the novel antidepressant viloxazine versus imipramine in 50 in-patients (author's transl)].

10. [Studies on a novel antidepressant (viloxazin) by means of time-series analysis of TV data].

1. Elevation of plasma phenytoin by viloxazine in epileptic patients: a clinically significant drug interaction.

2. Pharmacokinetics of the antidepressant drug viloxazine in normal subjects and in epileptic patients receiving chronic anticonvulsant treatment.

Review 3. Formation of active metabolites of psychotropic drugs. An updated review of their significance.

Review 4. Clinical pharmacokinetics of cerebrospinal fluid.

5. Determination of viloxazine in plasma by GLC.

Review 6. Current antidepressant drugs: their clinical use.

7. Comparison of the antimuscarinic activity of mianserin and amitriptyline in the cat superior cervical ganglion.

8. Theophylline intoxication following viloxazine induced decrease in clearance.

9. Age-related differences in kinetics and side-effects of viloxazine in man and their clinical implications.

10. The effect of some antidepressants on prejunctional muscarinic receptors on the sympathetic nerves of the isolated rabbit ear artery.